Pattern, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma: how do they matter?

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, not only in the United States, but also worldwide. And its incidence is rising. The prognosis is usually grave even after curative resection.